California, along with Massachusetts, New York, and New Jersey, has petitioned the FDA to relax recently imposed restrictions on the abortion pill mifepristone. The petitioners emphasize the drug's long-standing safety record and its importance for millions of women requiring timely and critical reproductive healthcare. California Atty. Gen. Rob Bonta highlighted that these restrictions disproportionately affect low-income women and those in rural areas. The petition also mentions accusations against Health and Human Services Secretary Robert F. Kennedy Jr. for using flawed data from anti-abortion activists to justify the new limits on this crucial medication.
The abortion pill mifepristone has been proven safe by millions of Americans over 25 years, and its restrictions threaten access particularly for vulnerable populations.
California and three other states argue the FDA's new restrictions on mifepristone are unnecessary, emphasizing the medication's critical role in women's healthcare.
Collection
[
|
...
]